Akcea Therapeutics Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Akcea Therapeutics are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Akcea Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Akcea Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Fifty Two Week Low | 8.00 | |
| Target High Price | 41.00 | |
| Fifty Two Week High | 21.70 | |
| Target Low Price | 16.00 |
Akcea |
Akcea Therapeutics Relative Risk vs. Return Landscape
If you would invest (100.00) in Akcea Therapeutics on January 26, 2024 and sell it today you would earn a total of 100.00 from holding Akcea Therapeutics or generate -100.0% return on investment over 90 days. Akcea Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Akcea, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Akcea Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Akcea Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Akcea Therapeutics, and traders can use it to determine the average amount a Akcea Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AKCA |
Based on monthly moving average Akcea Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Akcea Therapeutics by adding Akcea Therapeutics to a well-diversified portfolio.
Akcea Therapeutics Fundamentals Growth
Akcea Stock prices reflect investors' perceptions of the future prospects and financial health of Akcea Therapeutics, and Akcea Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Akcea Stock performance.
| Return On Equity | -9.8 | |||
| Return On Asset | -5.95 | |||
| Profit Margin | (12.34) % | |||
| Operating Margin | (13.60) % | |||
| Current Valuation | 1.47 B | |||
| Shares Outstanding | 101.61 M | |||
| Price To Earning | (10.02) X | |||
| Price To Book | 3.85 X | |||
| Price To Sales | 5.49 X | |||
| Revenue | 336.56 M | |||
| EBITDA | (39.09 M) | |||
| Cash And Equivalents | 389.89 M | |||
| Cash Per Share | 3.84 X | |||
| Total Debt | 14.76 M | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 4.72 X | |||
| Cash Flow From Operations | 96.47 M | |||
| Earnings Per Share | (0.56) X | |||
| Total Asset | 175.83 M | |||
| Retained Earnings | (519.26 M) | |||
| Current Asset | 174.18 M | |||
| Current Liabilities | 55.15 M | |||
Things to note about Akcea Therapeutics performance evaluation
Checking the ongoing alerts about Akcea Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Akcea Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Akcea Therapeutics is not yet fully synchronised with the market data | |
| Akcea Therapeutics has some characteristics of a very speculative penny stock | |
| Akcea Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 336.56 M. Net Loss for the year was (55.01 M) with profit before overhead, payroll, taxes, and interest of 185.72 M. | |
| About 83.0% of the company shares are held by company insiders |
- Analyzing Akcea Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Akcea Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Akcea Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Akcea Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Akcea Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Akcea Therapeutics' stock. These opinions can provide insight into Akcea Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Akcea Therapeutics information on this page should be used as a complementary analysis to other Akcea Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Akcea Stock
If you are still planning to invest in Akcea Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akcea Therapeutics' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |